ARCHIVES

QOL Of Young Survivors Equal To Other Children

This article is from The Cancer Letter archive.

Vol. 28 No. 2 | February 25, 2005

Download PDF Visit The Full Archive

Related Articles

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

October 14, 2005

Revlimid Maintenance Therapy Delayed Progression by 90%

May 27, 2011

Funding Opportunities

November 15, 2002

Don’t Blame FDA For All Problems, Broder Says

September 7, 1990

Republican Contenders Slam FDA Decision In Care Of Boy With Treatable Brain Tumor.

February 4, 2000

Human Genome Consortium Completes “Working Draft”.

June 30, 2000